BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12112112)

  • 1. Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome.
    Schlame M; Towbin JA; Heerdt PM; Jehle R; DiMauro S; Blanck TJ
    Ann Neurol; 2002 May; 51(5):634-7. PubMed ID: 12112112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome.
    Vreken P; Valianpour F; Nijtmans LG; Grivell LA; Plecko B; Wanders RJ; Barth PG
    Biochem Biophys Res Commun; 2000 Dec; 279(2):378-82. PubMed ID: 11118295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barth syndrome, a human disorder of cardiolipin metabolism.
    Schlame M; Ren M
    FEBS Lett; 2006 Oct; 580(23):5450-5. PubMed ID: 16973164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microanalysis of cardiolipin in small biopsies including skeletal muscle from patients with mitochondrial disease.
    Schlame M; Shanske S; Doty S; König T; Sculco T; DiMauro S; Blanck TJ
    J Lipid Res; 1999 Sep; 40(9):1585-92. PubMed ID: 10484605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell biology of cardiac mitochondrial phospholipids.
    Hatch GM
    Biochem Cell Biol; 2004 Feb; 82(1):99-112. PubMed ID: 15052331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial myopathies.
    DiMauro S
    Curr Opin Rheumatol; 2006 Nov; 18(6):636-41. PubMed ID: 17053512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced modification of cardiolipin during ischemia in the aged heart.
    Lesnefsky EJ; Minkler P; Hoppel CL
    J Mol Cell Cardiol; 2009 Jun; 46(6):1008-15. PubMed ID: 19303420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiolipin remodeling in the heart.
    Sparagna GC; Lesnefsky EJ
    J Cardiovasc Pharmacol; 2009 Apr; 53(4):290-301. PubMed ID: 19276988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.
    Zegallai HM; Hatch GM
    Mol Cell Biochem; 2021 Mar; 476(3):1605-1629. PubMed ID: 33415565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiolipin linoleic acid content and mitochondrial cytochrome c oxidase activity are associated in rat skeletal muscle.
    Fajardo VA; McMeekin L; Saint C; LeBlanc PJ
    Chem Phys Lipids; 2015 Apr; 187():50-5. PubMed ID: 25727371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysmorphology of Barth syndrome.
    Hastings R; Steward C; Tsai-Goodman B; Newbury-Ecob R
    Clin Dysmorphol; 2009 Oct; 18(4):185-7. PubMed ID: 19648820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure.
    Sparagna GC; Chicco AJ; Murphy RC; Bristow MR; Johnson CA; Rees ML; Maxey ML; McCune SA; Moore RL
    J Lipid Res; 2007 Jul; 48(7):1559-70. PubMed ID: 17426348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipid abnormalities in children with Barth syndrome.
    Schlame M; Kelley RI; Feigenbaum A; Towbin JA; Heerdt PM; Schieble T; Wanders RJ; DiMauro S; Blanck TJ
    J Am Coll Cardiol; 2003 Dec; 42(11):1994-9. PubMed ID: 14662265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiolipin deficiency in Barth syndrome is not associated with increased superoxide/H
    Goncalves RLS; Schlame M; Bartelt A; Brand MD; Hotamışlıgil GS
    FEBS Lett; 2021 Feb; 595(3):415-432. PubMed ID: 33112430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiolipin metabolism and the role it plays in heart failure and mitochondrial supercomplex formation.
    Mejia EM; Cole LK; Hatch GM
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):98-106. PubMed ID: 24801725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation.
    Auré K; Fayet G; Leroy JP; Lacène E; Romero NB; Lombès A
    Brain; 2006 May; 129(Pt 5):1249-59. PubMed ID: 16537564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial complex I dysfunction in rat heart with aging: critical role of reactive oxygen species and cardiolipin.
    Petrosillo G; Matera M; Moro N; Ruggiero FM; Paradies G
    Free Radic Biol Med; 2009 Jan; 46(1):88-94. PubMed ID: 18973802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid lowers cardiac mitochondrial enzyme activity by replacing linoleic acid in the phospholipidome.
    Sullivan EM; Pennington ER; Sparagna GC; Torres MJ; Neufer PD; Harris M; Washington J; Anderson EJ; Zeczycki TN; Brown DA; Shaikh SR
    J Biol Chem; 2018 Jan; 293(2):466-483. PubMed ID: 29162722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle carnitine deficiency and lipid storage myopathy in patients with mitochondrial myopathy.
    Campos Y; Huertas R; Bautista J; Gutiérrez E; Aparicio M; Lorenzo G; Segura D; Villanueva M; Cabello A; Alesso L
    Muscle Nerve; 1993 Jul; 16(7):778-81. PubMed ID: 8505934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroxine regulation of monolysocardiolipin acyltransferase activity in rat heart.
    Mutter T; Dolinsky VW; Ma BJ; Taylor WA; Hatch GM
    Biochem J; 2000 Mar; 346 Pt 2(Pt 2):403-6. PubMed ID: 10677359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.